Originally published in Applied Clinical Trials, July 2020.
The COVID-19 pandemic disrupted clinical trials worldwide and ushered in a new digital reality for clinical research. Remote visits, telemedicine, and decentralized models are now essential for patient safety and trial continuity.
This article explores how digital technologies, including ePROs, wearables, and BYOD strategies, have become integral to modern trials.
The author offers recommendations for navigating remote outcomes collection such as protocol design, standardization, and training considerations.
